Gene expression and pathologic response to neoadjuvant chemotherapy in breast cancer

Efficacy of Neoadjuvant Cisplatin in Triple-Negative Breast Cancer

Daniel P. Silver, Andrea L. Richardson, Aron C. Eklund et al. · Journal of Clinical Oncology · 2010 · 984 citations · Full text

Medicine, Oncology, Pharmacology +16

A Comparison of PAM50 Intrinsic Subtyping with Immunohistochemistry and Clinical Prognostic Factors in Tamoxifen-Treated Estrogen Receptor–Positive Breast Cancer

Torsten O. Nielsen, Joel S. Parker, Samuel Leung et al. · Clinical Cancer Research · 2010 · 824 citations · Full text

Medicine, Biostatistics, Oncology +16

T-cell metagene predicts a favorable prognosis in estrogen receptor-negative and HER2-positive breast cancers

Achim Rody, Uwe Holtrich, L. Pusztai et al. · Breast Cancer Research · 2009 · 482 citations · Full text

Medicine, Cancer Biology, Oncology +17

FOXC1 Is a Potential Prognostic Biomarker with Functional Significance in Basal-like Breast Cancer

Partha Ray, Jinhua Wang, Ying Qu et al. · Cancer Research · 2010 · 233 citations

Medicine, Molecular Biology, Oncology +17

Building prognostic models for breast cancer patients using clinical variables and hundreds of gene expression signatures

Cheng Fan, Aleix Prat, Joel S. Parker et al. · BMC Medical Genomics · 2011 · 197 citations · Full text

Medicine, Biostatistics, Oncology +17